Icahn School of Medicine

The University of Texas MD Anderson Cancer Center and US/UK biotech Replay announced on 14 February that they are launching a new company, Syena, to advance research conducted at the cancer center o

Eisai Co., Ltd. and Biogen, Inc. should hear from the US Food and Drug Administration any day now whether the agency will grant accelerated approval for the amyloid protofibril-targeting antibody l

Eisai Co., Ltd. and Biogen, Inc. should hear from the US Food and Drug Administration any day now whether the agency will grant accelerated approval for the amyloid protofibril-targeting antibody l

Glenmark Pharmaceuticals Limited , is progressing its small-molecule hematopoietic progenitor kinase 1 (HPK1) inhibitor, GRC 54276, joining a select but growing list of firms pursuing the promising th